ZYME

Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Total revenue 27.11 M48.73 M27.61 M2.52 M2.41 M 81.26 M Gross profit 27.11 M48.73 M27.61 M2.52 M2.41 M 81.26 M Operating expenses 52.72 M49.4 M49.72 M46.67 M49.53 M 195.32 M Selling/general/admin expenses 16.98 M14.95 M14.15 M15.43 M15.07 M 59.6 M Research & development 35.74 M34.45 M35.58 M31.23 M34.46 M 135.72 M Operating income -25.61 M-674 K-22.11 M-44.15 M-47.12 M -114.05 M Non-Operating Income, Total 49 K-621 K315 K-302 K120 K -488 K Interest expense, net of interest capitalized ————26 K — Non-Operating Income, excl. Interest Expenses -2 000-613 K289 K-284 K120 K -488 K Unusual income/expense 51 K-8 00026 K-18 K— — Pretax income -22.14 M2.13 M-18.27 M-41.48 M-46.35 M -103.97 M Equity in earnings ————— — Taxes 496 K-186 K1.34 M-270 K-2.19 M -1.31 M Non-controlling/minority interest ————— — After tax other income/expense ————— — Net income before discontinued operations -22.64 M2.32 M-19.6 M-41.21 M-44.16 M -102.66 M Discontinued operations ————— — Net income -22.64 M2.32 M-19.6 M-41.21 M-44.16 M -102.66 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders -22.81 M2.32 M-19.77 M-41.06 M-44.22 M -102.73 M Basic earnings per share (Basic EPS) -0.30.03-0.26-0.55-0.59 -1.37 Diluted earnings per share (Diluted EPS) -0.30.03-0.26-0.55-0.59 -1.37 Average basic shares outstanding 75.17 M75.34 M75.77 M75.4 M74.67 M — Diluted shares outstanding 75.23 M77.38 M75.78 M75.41 M74.69 M — EBITDA -23.02 M3.43 M-17.33 M-39.2 M-45.19 M -98.28 M EBIT -25.61 M-674 K-22.11 M-44.15 M-47.12 M -114.05 M Cost of revenue ————— — Other cost of goods sold ————— — Depreciation & amortization (cash flow) 2.6 M4.11 M4.78 M4.95 M1.93 M 15.77 M